Berenberg analyst Kerry Holford lowered the price target on Novartis (NOVN:SW) (NYSE: NVS) to CHF105.00 (from CHF120.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE